240 related articles for article (PubMed ID: 27693373)
21. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of miltefosine treatment in Leishmania amazonensis-infected BALB/c mice.
Godinho JL; Simas-Rodrigues C; Silva R; Ürmenyi TP; de Souza W; Rodrigues JC
Int J Antimicrob Agents; 2012 Apr; 39(4):326-31. PubMed ID: 22226653
[TBL] [Abstract][Full Text] [Related]
23. Coadminstration of L. major amastigote class I nuclease (rLmaCIN) with LPD nanoparticles delays the progression of skin lesion and the L. major dissemination to the spleen in BALB/c mice-based experimental setting.
Fakhraee F; Badiee A; Alavizadeh SH; Jalali SA; Chavoshian O; Khamesipour A; Mahboudi F; Jaafari MR
Acta Trop; 2016 Jul; 159():211-8. PubMed ID: 27060774
[TBL] [Abstract][Full Text] [Related]
24. A nanotechnology based new approach for chemotherapy of Cutaneous Leishmaniasis: TIO2@AG nanoparticles - Nigella sativa oil combinations.
Abamor ES; Allahverdiyev AM
Exp Parasitol; 2016 Jul; 166():150-63. PubMed ID: 27109311
[TBL] [Abstract][Full Text] [Related]
25. Treatment with synthetic lipophilic tyrosyl ester controls Leishmania major infection by reducing parasite load in BALB/c mice.
Sghaier RM; Aissa I; Attia H; Bali A; Leon Martinez PA; Mkannez G; Guerfali FZ; Gargouri Y; Laouini D
Parasitology; 2016 Oct; 143(12):1615-21. PubMed ID: 27312247
[TBL] [Abstract][Full Text] [Related]
26. The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis.
Rodrigues RF; Charret KS; Campos MC; Amaral V; Echevarria A; Dos Reis C; Canto-Cavalheiro MM; Leon LL
J Antimicrob Chemother; 2012 Jan; 67(1):182-90. PubMed ID: 21987238
[TBL] [Abstract][Full Text] [Related]
27. In vivo antileishmanial action of Ir-(COD)-pentamidine tetraphenylborate on Leishmania donovani and Leishmania major mouse models.
Loiseau PM; Mbongo N; Bories C; Boulard Y; Craciunescu DG
Parasite; 2000 Jun; 7(2):103-8. PubMed ID: 10887656
[TBL] [Abstract][Full Text] [Related]
28. The sesquiterpene (-)-α-bisabolol is active against the causative agents of Old World cutaneous leishmaniasis through the induction of mitochondrial-dependent apoptosis.
Corpas-López V; Merino-Espinosa G; Díaz-Sáez V; Morillas-Márquez F; Navarro-Moll MC; Martín-Sánchez J
Apoptosis; 2016 Oct; 21(10):1071-81. PubMed ID: 27539477
[TBL] [Abstract][Full Text] [Related]
29. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A
J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476
[TBL] [Abstract][Full Text] [Related]
30. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
von Stebut E; Belkaid Y; Nguyen BV; Cushing M; Sacks DL; Udey MC
Eur J Immunol; 2000 Dec; 30(12):3498-506. PubMed ID: 11093169
[TBL] [Abstract][Full Text] [Related]
31. Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity.
Casa DM; Scariot DB; Khalil NM; Nakamura CV; Mainardes RM
Exp Parasitol; 2018 Sep; 192():12-18. PubMed ID: 30026113
[TBL] [Abstract][Full Text] [Related]
32. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of histamine H1 receptor antagonists azelastine and fexofenadine against cutaneous Leishmania major infection.
Peniche AG; Osorio EY; Melby PC; Travi BL
PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008482. PubMed ID: 32776923
[TBL] [Abstract][Full Text] [Related]
34. Leishmania amazonensis: effects of oral treatment with copaiba oil in mice.
dos Santos AO; Costa MA; Ueda-Nakamura T; Dias-Filho BP; da Veiga-Júnior VF; de Souza Lima MM; Nakamura CV
Exp Parasitol; 2011 Oct; 129(2):145-51. PubMed ID: 21771592
[TBL] [Abstract][Full Text] [Related]
35. An 8-hydroxyquinoline-containing polymeric micelle system is effective for the treatment of murine tegumentary leishmaniasis.
Lage LM; Barichello JM; Lage DP; Mendonça DV; Carvalho AM; Rodrigues MR; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Coelho EA; Duarte MC
Parasitol Res; 2016 Nov; 115(11):4083-4095. PubMed ID: 27365053
[TBL] [Abstract][Full Text] [Related]
36. Anti-Leishmanial Activity (In Vitro and In Vivo) of Allicin and Allicin Cream Using Leishmania major (Sub-strain Zymowme LON4) and Balb/c Mice.
Metwally DM; Al-Olayan EM; El-Khadragy MF; Alkathiri B
PLoS One; 2016; 11(8):e0161296. PubMed ID: 27537199
[TBL] [Abstract][Full Text] [Related]
37. Investigation of anti-leishmanial efficacy of miltefosine and ketoconazole loaded on nanoniosomes.
Nazari-Vanani R; Vais RD; Sharifi F; Sattarahmady N; Karimian K; Motazedian MH; Heli H
Acta Trop; 2018 Sep; 185():69-76. PubMed ID: 29733808
[TBL] [Abstract][Full Text] [Related]
38. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA
Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166
[TBL] [Abstract][Full Text] [Related]
39. Gallic and ellagic acids: two natural immunomodulator compounds solve infection of macrophages by Leishmania major.
Alves MMM; Brito LM; Souza AC; Queiroz BCSH; de Carvalho TP; Batista JF; Oliveira JSSM; de Mendonça IL; Lira SRS; Chaves MH; Gonçalves JCR; Carneiro SMP; Arcanjo DDR; Carvalho FAA
Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):893-903. PubMed ID: 28643086
[TBL] [Abstract][Full Text] [Related]
40. Activity of pentostam (sodium stibogluconate) against cutaneous leishmaniasis in mice treated with neutralizing anti-interferon-gamma antibody.
Nabors GS; Farrell JP
Am J Trop Med Hyg; 1995 Jul; 53(1):55-60. PubMed ID: 7625533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
